Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Gilead Sciences sofosbuvir (Epclusa / Harvoni / Vosevi) intangible asset — Net carrying value ($M) ($M)
Form 10-Q / 10-K Note 9 Goodwill and Intangible Assets
Latest, FY2025
2,272
Period ended Dec 31, 2025
Change on a year earlier
-23.5%
2,971 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Sofosbuvir (Epclusa / Harvoni / Vosevi) intangible asset — Net carrying value ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,272 | -23.5% | Form 10-Q (filed 2026-08-06) ↗ |
| FY2024 | Dec 31, 2024 | 2,971 | -19.0% | Form 10-K (filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 3,670 | -16.0% | Form 10-K (filed 2025-02-28) ↗ |
| FY2022 | Dec 31, 2022 | 4,370 | -13.8% | Form 10-K (filed 2024-02-23) ↗ |
| FY2021 | Dec 31, 2021 | 5,069 | -12.1% | Form 10-K (filed 2023-02-22) ↗ |
| FY2020 | Dec 31, 2020 | 5,768 | -10.8% | Form 10-K (filed 2022-02-23) ↗ |
| FY2019 | Dec 31, 2019 | 6,467 | -9.8% | Form 10-Q (filed 2020-05-06) ↗ |
| FY2018 | Dec 31, 2018 | 7,166 | -8.9% | Form 10-Q (filed 2019-11-05) ↗ |
| FY2017 | Dec 31, 2017 | 7,865 | -8.2% | Form 10-K (filed 2019-02-26) ↗ |
| FY2016 | Dec 31, 2016 | 8,564 | -7.6% | Form 10-K (filed 2018-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 9,264 | – | Form 10-K (filed 2017-02-27) ↗ |
Breakdown
What makes up sofosbuvir (epclusa / harvoni / vosevi) intangible asset — net carrying value ($m)
Cite this data
StockData. (2026). Gilead Sciences Sofosbuvir (Epclusa / Harvoni / Vosevi) intangible asset — Net carrying value ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/intang_sofosbuvir_net
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.